HCW Biologics(HCWB) - 2024 Q1 - Quarterly Results

Exhibit 99.1 HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights Financial Guidance Miramar, FL – May 15, 2024 – HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, ...